T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
T3 Pharmaceuticals has raised €23M across 1 funding round, most recently a round in Jul 2020. Based in Basel, Switzerland; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-07-22 | Other | €23M |
| — |
| View deal → |
